While previous studies have reported that the transcript levels of BCAA catabolic enzymes are down-regulated in ccRCC (5, 28), the molecular mechanisms underlying this defective BCAA catabolism and its consequent role in RCC tumor progression were not studied. This evidence concerns the gene ARID4B and neoplasm.